Detalhe da pesquisa
1.
Lurbinectedin as second- or third-line palliative therapy in malignant pleural mesothelioma: an international, multi-centre, single-arm, phase II trial (SAKK 17/16).
Ann Oncol
; 31(4): 495-500, 2020 04.
Artigo
Inglês
| MEDLINE | ID: mdl-32085891
2.
Malignant pleural mesothelioma immune microenvironment and checkpoint expression: correlation with clinical-pathological features and intratumor heterogeneity over time.
Ann Oncol
; 29(5): 1258-1265, 2018 05 01.
Artigo
Inglês
| MEDLINE | ID: mdl-29514216
3.
On the relationship between androgen-deprivation therapy for prostate cancer and risk of infection by SARS-CoV-2.
Ann Oncol
; 31(10): 1415-1416, 2020 10.
Artigo
Inglês
| MEDLINE | ID: mdl-32562741
4.
Improvement in survival and quality of life with new therapeutic agents in metastatic castration-resistant prostate cancer: comparison among the results.
Q J Nucl Med Mol Imaging
; 59(4): 400-10, 2015 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-26337241
5.
Role of chemotherapy in combination with hormonal therapy in first-line treatment of metastatic hormone-sensitive prostate cancer.
Q J Nucl Med Mol Imaging
; 59(4): 374-80, 2015 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-26222275
6.
Prognostic factors in elderly patients with malignant pleural mesothelioma: results of a multicenter survey.
Br J Cancer
; 111(2): 220-6, 2014 Jul 15.
Artigo
Inglês
| MEDLINE | ID: mdl-24918816
7.
Phase II study of pemetrexed and carboplatin plus bevacizumab as first-line therapy in malignant pleural mesothelioma.
Br J Cancer
; 109(3): 552-8, 2013 Aug 06.
Artigo
Inglês
| MEDLINE | ID: mdl-23860535
8.
Final results of DIADEM, a phase II study to investigate the efficacy and safety of durvalumab in advanced pretreated malignant pleural mesothelioma.
ESMO Open
; 7(6): 100644, 2022 12.
Artigo
Inglês
| MEDLINE | ID: mdl-36463732
9.
Long-term benefit of lurbinectedin as palliative chemotherapy in progressive malignant pleural mesothelioma (MPM): final efficacy and translational data of the SAKK 17/16 study.
ESMO Open
; 7(3): 100446, 2022 06.
Artigo
Inglês
| MEDLINE | ID: mdl-35427834
10.
Nuclear medicine and the revolution in the modern management of castration-resistant prostate cancer patients: from (223)Ra-dichloride to new horizons for therapeutic response assessment.
Eur J Nucl Med Mol Imaging
; 43(1): 5-7, 2016 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-26381776
11.
Treating disease progression with osimertinib in EGFR-mutated non-small-cell lung cancer: novel targeted agents and combination strategies.
ESMO Open
; 6(6): 100280, 2021 12.
Artigo
Inglês
| MEDLINE | ID: mdl-34634633
12.
Metronomic oral vinorelbine in previously untreated advanced non-small-cell lung cancer patients unfit for platinum-based chemotherapy: results of the randomized phase II Tempo Lung trial.
ESMO Open
; 6(2): 100051, 2021 04.
Artigo
Inglês
| MEDLINE | ID: mdl-33611164
13.
Role of of Nuclear Medicine in the multidisciplinary management of prostate cancer.
Q J Nucl Med Mol Imaging
; 59(4): 357-8, 2015 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-26416035
14.
Differential diagnosis and management of focal ground-glass opacities.
Eur Respir J
; 33(4): 821-7, 2009 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-19047318
15.
Pemetrexed plus carboplatin in elderly patients with malignant pleural mesothelioma: combined analysis of two phase II trials.
Br J Cancer
; 99(1): 51-6, 2008 Jul 08.
Artigo
Inglês
| MEDLINE | ID: mdl-18542071
16.
Role of cMET expression in non-small-cell lung cancer patients treated with EGFR tyrosine kinase inhibitors.
Ann Oncol
; 19(9): 1605-12, 2008 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-18467317
17.
Serum level changes of matrix metalloproteinases 2 and 9, vascular endothelial growth factor and epidermal growth factor receptor during platinum-based chemotherapy in advanced non-small cell lung cancer patients.
J BUON
; 12(1): 105-11, 2007.
Artigo
Inglês
| MEDLINE | ID: mdl-17436410
18.
EGFR overexpression in malignant pleural mesothelioma. An immunohistochemical and molecular study with clinico-pathological correlations.
Lung Cancer
; 51(2): 207-15, 2006 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-16384623
19.
New tricks for old biomarkers: thymidylate synthase expression as a predictor of pemetrexed activity in malignant mesothelioma.
Ann Oncol
; 21(7): 1560-1561, 2010 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-20447928
20.
Effect on local control and survival of electron beam intraoperative irradiation for resectable pancreatic adenocarcinoma.
Int J Radiat Oncol Biol Phys
; 50(3): 651-8, 2001 Jul 01.
Artigo
Inglês
| MEDLINE | ID: mdl-11395232